FDA to Improve How Food Processors Submit Information to FDA – New Approach to Reduce Errors and Improve Public Health Protection
Print this Article | Send to Colleague
On September 18, 2013, The Food and Drug Administration (FDA) published a Federal Register notice, "Agency Information Collection Activities; Proposed Collection; Comment Request; Food Canning Establishment Registration, Process Filing, and Record-keeping for Acidified Foods and Thermally Processed Low-Acid Foods in Hermetically Sealed Containers". FDA is seeking to make it easier for manufacturers of acidified and low-acid canned foods (LACF) to submit information about their manufacturing processes to FDA and to improve the accuracy of the information they provide. FDA is doing this by modernizing both the paper and electronic process filing forms that acidified and low-acid canned food manufacturers are required to file with the agency under 21 CFR 108.25(c)(2) and 21 CFR 108.35(c)(2).
As part of this modernization, FDA will stop using Form 2541a and Form 2541c to collect information from manufacturers and will begin using forms that are specific to the different industry manufacturing processes. In the future, acidified and low-acid canned food manufacturers will be able to submit one or more of the process filing forms listed below, depending on the processing methods they use.
The new forms will be easier to use and reduce any confusion about the type of information FDA needs from a manufacturer to evaluate the adequacy of its processes. This, in turn, will enable FDA to better ensure the safety of acidified and low-acid canned foods.
The new forms will be available in paper and electronic format. The electronic forms will mirror the paper forms.
Before FDA begins using the new forms, stakeholders will have two opportunities to comment on them. First, stakeholders will have an opportunity to comment on specific topics relevant to the collection of information in the forms and the Paperwork Reduction Act. Second, at a future date, stakeholders will have an opportunity to comment more broadly on the content of the forms and how the forms will be integrated into the process for submitting information about their manufacturing processes as required by 21 CFR 108.25 and 21 CFR 108.35, when FDA publishes related draft guidance.
Manufacturers should continue using the Forms 2541a and 2541c until the new forms are finalized and formally adopted.
The opportunity to comment will be open until November 18, 2013.
Questions about the paperwork and regulatory burdens of the information collection may be directed to the PRA Staff of the FDA Office of Operations in Rockville, Maryland by email at PRAStaff@FDA.HHS.gov
This article was distributed by the U. S. Food & Drug Administration.
Back to In the View Homepage
![Share on LinkedIn](https://www.naylornetwork.com/cfp-nwl/images/linked-in-icon.png)
|